Skip to main content
Fig. 3 | Journal of Biomedical Science

Fig. 3

From: Targeted antitumor prodrug therapy using CNGRC-yCD fusion protein in combination with 5-fluorocytosine

Fig. 3

APN expression levels in various types of cell lines. Tumor cells were grown to 90 % confluent and HUVECs was grown to 50 % and 90 % confluent. Cells were probed with anti-APN antibody (WM15) and then with secondary antibody conjugated with Alexa488. The levels of APN expression for all cell lines were analyzed by flow cytometry. At least three repeats were performed with similar results

Back to article page